Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory DiseasesReview Published on 2014-07-172022-10-28 Journal: Viruses [Category] Coronavirus, [키워드] addressed biosafety can be used caused cellular immune responses coronavirus coronavirus Coronaviruses develop foreign antigen function human parainfluenza virus humoral induce Infection Influenza Influenza virus influenza virus influenza viruses intrinsic limitations modified vaccinia virus Ankara multivalent vaccine Other pandemic parainfluenza virus Production protective immunity public health Regulatory replication-deficient viral vector respiratory respiratory syncytial virus respiratory virus respiratory viruses respond RSV Seasonal influenza Subtypes target Vaccine Vaccine development vaccine platform vaccinia virus [DOI] 10.3390/v6072735 PMC 바로가기 [Article Type] Review
Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza VirusesResearch Article Published on 2013-08-302022-10-28 Journal: PLoS ONE [Category] Coronavirus, [키워드] African aminopeptidase N analyzed angiotensin-converting enzyme 2 bat bovine Carollia Cell cell line cell lines cellular receptor coronavirus coronavirus CoV different Efficiency enveloped RNA viruses Express Filoviridae filovirus filoviruses gastroenteritis Host implication infect Infected Infection influenza virus influenza viruses Isolation overcome pathogenic virus Protein pseudotype resistance to infection respiratory syncytial virus RNA SARS-coronavirus SARS-CoV SARS-related CoV Sendai virus Subtypes surface protein susceptibility Tadarida tested TGEV the S protein the Spike vesicular stomatitis virus virus VSV Yangochiroptera Yinpterochiroptera [DOI] 10.1371/journal.pone.0072942 PMC 바로가기 [Article Type] Research Article
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral DrugsResearch Published on 2004-04-012022-10-31 Journal: Emerging Infectious Diseases [Category] Coronavirus, [키워드] acute respiratory syndrome agents Antiviral Antiviral agents antiviral drug antiviral drugs antivirals approved caused clinical testing clinically Compound coronavirus Coronavirus infection Culture cultured cell Cytopathic effect drug effective in vitro Infectious disease inhibition inhibitors interferon interferons investigated leukocyte neuraminidase inhibitors nucleoside analogs protease inhibitors SARS virus SARS-CoV SARS-CoV infection severe Severe acute respiratory syndrome Subtypes Support transcriptase treat Treatment was used [DOI] 10.3201/eid1004.030458 PMC 바로가기 [Article Type] Research